286 filings
ARS
2023 FY
BPMC
Blueprint Medicines Corp
25 Apr 24
Annual report to shareholders
5:25pm
DEF 14A
BPMC
Blueprint Medicines Corp
Definitive proxy
25 Apr 24
5:24pm
8-K
BPMC
Blueprint Medicines Corp
25 Apr 24
Other Events
8:30am
8-K
BPMC
Blueprint Medicines Corp
22 Feb 24
Other Events
8:20am
S-8
BPMC
Blueprint Medicines Corp
16 Feb 24
Registration of securities for employees
4:40pm
8-K
605c ho0metmx4
15 Feb 24
Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results
7:05am
8-K
w3dq6fms
8 Jan 24
Blueprint Medicines Highlights 2024 Corporate Strategy and Business Priorities at 42nd Annual J.P. Morgan Healthcare Conference
8:03am
8-K
amw9tu xyym747akyey
26 Oct 23
Blueprint Medicines Reports Third Quarter 2023 Results
7:00am
8-K
hu7kwqvjzvp
25 Aug 23
Other Events
8:15am
8-K
8s98prc
2 Aug 23
Blueprint Medicines Reports Second Quarter 2023 Results
7:00am
8-K
3khv35u4nunql8mkta
30 Jun 23
Other Events
6:03am
8-K
uqwfyr8ktpo1twp
27 Jun 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
cf0oka5z
25 May 23
Entry into a Material Definitive Agreement
4:32pm
8-K
wb5lm
22 May 23
FDA Approves AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis
4:53pm
8-K
eym5dceqtd cbecfp
4 May 23
Blueprint Medicines Reports First Quarter 2023 Results
7:18am
ARS
5xl sa1qy
28 Apr 23
Annual report to shareholders
5:47pm